High-dose chemotherapy and autologous hematopoietic stem cell transplantation in myeloma patients under the age of 65 years.
about
Top Information Need Priorities of Older Adults Newly Diagnosed With Active MyelomaAnalysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry.Current status of autologous hematopoietic stem cell transplantation in myeloma.Treatment of myeloma: cure vs controlSecond auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma.Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myeloma.Managing multiple myeloma in the elderly: are we making progress?Current therapeutic strategies for multiple myeloma.Second auto-SCT for treatment of relapsed multiple myeloma.Toxicity of a second autologous peripheral blood stem cell transplant in patients with relapsed or recurrent multiple myeloma.A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control.Matched-pair analysis to compare the outcomes of a second salvage auto-SCT to systemic chemotherapy alone in patients with multiple myeloma who relapsed after front-line auto-SCT.Actual or ideal body weight to calculate CD34+ cell dose in patients undergoing autologous hematopoietic SCT for myeloma?Optimal mobilization method and CD34+ dose calculation for autologous PBSC transplant in myeloma patients: two important unresolved questions.Impact of early relapse after auto-SCT for multiple myeloma.
P2860
Q26785735-AABA8100-CC65-4E46-A075-9511DAA80DB7Q36498366-85BDEF83-7D21-4872-BD81-E4246826A264Q37251047-9BD1ED2E-956B-45CD-A706-5C13EEE7BA92Q37284081-A7E84B07-3440-4294-AB5A-1400BC44E96DQ37375819-6E99085D-83E9-44EE-B803-EE95729A8F02Q37411236-D8BD63C7-489B-44F7-BEA8-2F4D1026C277Q37888716-93A578E0-38B0-4002-AA7F-7D80383F7DA8Q38412189-03EF2BDE-FC40-41ED-893D-F2BCDEA4CC53Q44758991-4B00F991-86CC-4C6C-A9C6-033C7852DB4DQ45918038-30B44FF2-B58A-4A43-8455-B497416030A7Q46440869-94E82CCE-2093-4178-B51D-E439F98129DFQ47196540-34505E3F-EFE3-409E-9C1D-F3DFD79EF1EFQ47212803-A8062272-B9F8-4556-9AA8-DDE46CEB8EF1Q47966106-FCFB5DA0-6213-4731-9E36-22F4CB35429CQ53469257-E996FF64-A7F6-4E1D-872D-93DC69AB69E9
P2860
High-dose chemotherapy and autologous hematopoietic stem cell transplantation in myeloma patients under the age of 65 years.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
High-dose chemotherapy and aut ...... nts under the age of 65 years.
@en
type
label
High-dose chemotherapy and aut ...... nts under the age of 65 years.
@en
prefLabel
High-dose chemotherapy and aut ...... nts under the age of 65 years.
@en
P2860
P356
P1476
High-dose chemotherapy and aut ...... nts under the age of 65 years.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BMT.1705799
P407
P577
2007-08-06T00:00:00Z